Peter Samuel Wulff

Directeur/Membre du Conseil chez Sementis Ltd.

Profil

Peter Samuel Wulff was the founder of Bavarian Nordic A, founded in 1992, where he held the title of President & Chief Executive Officer.
He is also the founder of Sentinext Therapeutics Sdn.
Bhd., founded in 2009, where he held the title of Chief Executive Officer from 2010 to 2012.
Additionally, he is the founder of iSD Immunotech ApS, founded in 2007, where he held the title of Chairman from 2007 to 2015.
Mr. Wulff's current job is as a Director at Sementis Ltd. Mr. Wulff's former jobs include Chairman at Inagen ApS, Director-Patents & Licensing at NTG Nordic Transport Group A from 1989 to 1997, Director-Patents & Licensing at Ferrosan ApS from 1987 to 1989, Director at MedArt A, Director at Dansk Biotek, and Director at Spago Nanomedical AB. Mr. Wulff received his undergraduate degree in 1979 and his graduate degree in 1980 from the University of Copenhagen.
Mr. Wulff is also the founder of IMSK SE.

Postes actifs de Peter Samuel Wulff

Sociétés	Poste	Début
Sementis Ltd.	Directeur/Membre du Conseil	-

Anciens postes connus de Peter Samuel Wulff

Sociétés	Poste	Fin
iSD Immunotech ApS	Fondateur	14/07/2015
BAVARIAN NORDIC A/S	Directeur Général	29/04/2007
NTG NORDIC TRANSPORT GROUP A/S	Corporate Officer/Principal	01/01/1997
Ferrosan ApS	Corporate Officer/Principal	01/01/1989
SPAGO NANOMEDICAL AB	Directeur/Membre du Conseil	-